GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (OTCPK:CAMRF) » Definitions » Price-to-Tangible-Book

CAMRF (Camurus AB) Price-to-Tangible-Book : 9.92 (As of Dec. 12, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Camurus AB Price-to-Tangible-Book?

As of today (2024-12-12), Camurus AB's share price is $50.965. Camurus AB's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was $5.14. Hence, Camurus AB's Price to Tangible Book Ratio of today is 9.92.

The historical rank and industry rank for Camurus AB's Price-to-Tangible-Book or its related term are showing as below:

CAMRF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.22   Med: 11.25   Max: 20.35
Current: 10.4

During the past 13 years, Camurus AB's highest Price to Tangible Book Ratio was 20.35. The lowest was 4.22. And the median was 11.25.

CAMRF's Price-to-Tangible-Book is ranked worse than
87.03% of 1203 companies
in the Biotechnology industry
Industry Median: 2.93 vs CAMRF: 10.40

A closely related ratio is called PB Ratio. As of today, Camurus AB's share price is $50.965. Camurus AB's Book Value per Sharefor the quarter that ended in Sep. 2024 was $5.17. Hence, Camurus AB's P/B Ratio of today is 9.85.


Camurus AB Price-to-Tangible-Book Historical Data

The historical data trend for Camurus AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Price-to-Tangible-Book Chart

Camurus AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.58 7.21 7.89 12.92 8.46

Camurus AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.16 8.46 10.56 12.32 12.05

Competitive Comparison of Camurus AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Camurus AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Camurus AB's Price-to-Tangible-Book falls into.



Camurus AB Price-to-Tangible-Book Calculation

Camurus AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=50.965/5.137
=9.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Camurus AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Camurus AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

From GuruFocus

Full Year 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q2 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q2 2024 Camurus AB Earnings Call Transcript

By GuruFocus Research 07-17-2024

Q1 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Half Year 2023 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q1 2022 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q3 2024 Camurus AB Earnings Call Transcript

By GuruFocus News 11-09-2024

Camurus AB Special Call Transcript

By GuruFocus Research 03-02-2024

Q1 2024 Camurus AB Earnings Call Transcript

By GuruFocus Research 05-09-2024